These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 4726921

  • 1. The effect of treatment with long-term chelating agents on iron overload in thalassaemia.
    Letsky EA, Flynn DM, Barry M.
    Br J Haematol; 1973 Aug; 25(2):285. PubMed ID: 4726921
    [No Abstract] [Full Text] [Related]

  • 2. A controlled trial of long-term chelation therapy in homozygous beta-thalassemia.
    Letsky EA.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):31-41. PubMed ID: 1009233
    [No Abstract] [Full Text] [Related]

  • 3. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ, Weatherall DJ.
    Haematologia (Budap); 1984 Aug; 17(1):17-24. PubMed ID: 6724353
    [Abstract] [Full Text] [Related]

  • 4. Proceedings: 5-year controlled trial of chelating agents in treatment of thalassaemia major.
    Flynn DM.
    Arch Dis Child; 1973 Oct; 48(10):829. PubMed ID: 4584225
    [No Abstract] [Full Text] [Related]

  • 5. New treatment for patients with iron overload.
    Griffith P, Burks J.
    J Nurs Care; 1978 Sep; 11(9):12-4. PubMed ID: 308223
    [No Abstract] [Full Text] [Related]

  • 6. Thalassemia.
    Brown EB.
    Prog Clin Biol Res; 1983 Sep; 127():33-42. PubMed ID: 6889403
    [No Abstract] [Full Text] [Related]

  • 7. Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.
    Peterson CM, Graziano JH, Grady RW, Jones RL, Markenson A, Lavi U, Canale V, Gray GF, Cerami A, Miller DR.
    Exp Hematol; 1979 Feb; 7(2):74-80. PubMed ID: 371974
    [Abstract] [Full Text] [Related]

  • 8. Serum ferritin in children with thalassaemia regularly transfused.
    Letsky EA, Miller F, Worwood M, Flynn DM.
    J Clin Pathol; 1974 Aug; 27(8):652-5. PubMed ID: 4421996
    [Abstract] [Full Text] [Related]

  • 9. The relation between liver iron concentration and liver damage in transfusional iron overload in thalassaemia and the effect of chelation therapy.
    Risdon RA, Flynn DM, Barry M.
    Gut; 1973 May; 14(5):421. PubMed ID: 4716515
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of iron overload in Cooley's anemia.
    Cohen A, Mizanin J, Schwartz E.
    Ann N Y Acad Sci; 1985 May; 445():274-81. PubMed ID: 3860130
    [No Abstract] [Full Text] [Related]

  • 11. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
    Flynn DM, Hoffbrand AV, Politis D.
    Birth Defects Orig Artic Ser; 1982 May; 18(7):347-53. PubMed ID: 6819017
    [No Abstract] [Full Text] [Related]

  • 12. Recognition and treatment of iron overload.
    Brown EB.
    Adv Intern Med; 1980 May; 26():159-86. PubMed ID: 7013439
    [No Abstract] [Full Text] [Related]

  • 13. [Secondary iron overload].
    Galacteros F.
    Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():44-8. PubMed ID: 9827215
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antioxidant micronutrients in children with thalassaemia in Egypt.
    Nasr MR, Ali S, Shaker M, Elgabry E.
    East Mediterr Health J; 2002 Jul; 8(4-5):490-5. PubMed ID: 15603029
    [Abstract] [Full Text] [Related]

  • 16. Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.
    Barry M, Flynn DM, Letsky EA, Risdon RA.
    Br Med J; 1974 Apr 06; 2(5909):16-20. PubMed ID: 4821036
    [Abstract] [Full Text] [Related]

  • 17. The development of new drugs for use in iron chelation therapy.
    Grady RW.
    Birth Defects Orig Artic Ser; 1976 Apr 06; 12(8):161-75. PubMed ID: 795480
    [No Abstract] [Full Text] [Related]

  • 18. Hemolytic anemia: thalassemia syndromes.
    Propper RD.
    Pediatr Ann; 1980 Aug 06; 9(8):300-7. PubMed ID: 7413285
    [No Abstract] [Full Text] [Related]

  • 19. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.
    Porter JB, Davis BA.
    Best Pract Res Clin Haematol; 2002 Jun 06; 15(2):329-68. PubMed ID: 12401311
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and management of thalassaemia.
    Peters M, Heijboer H, Smiers F, Giordano PC.
    BMJ; 2012 Jan 25; 344():e228. PubMed ID: 22277544
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.